Followers | 0 |
Posts | 1,934 |
Boards Moderated | 0 |
Alias Born | 03/04/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PAOG stil gaining critical awareness.
$PAOG great level for accumulation.
$RBII Cannophen finding more and more distribution channels.
Nice we have update today, looks like Art is working. $RBII
Cannophen Capsules and Vape Cartridges will be a game changer for this sector. $RBII
Cannophen will be a game changer in this sector. Time to get the word out. $PAOG
$PAOG Cannophen pilot production run was a smashing success.
Great exposure for $PAOG. Karl does a good job encapsulating all the developments.
Cannophen features a 1 to 1 CBD and THC distillate for rabid absorbtion and maxium effectiveness of the active compounds. $PAOG
What a bargain this is right now. Like gift truly. $PAOG
$RBII Combating the Opioid Crisis is something I can get behind.
$RBII Nice action this morning.
$PAOG debuted some pre-production samples of Cannophen vape cartridge at the Cannabis Cup.
For further details about the HIGH TIMES Cannabis Cup Michigan, please visit: https://www.cannabiscup.com/event/high-times-cannabis-cup-michigan-2019/4
Cannophen is manufactured in Michigan by HIGH END Products, LLC under license by Rising BioSciences, Inc. (OTC: RBII).
Cannophen™ capsules were available to attendees of the Cannabis Cup, which was open to Michigan medical marihuana cardholders 18+ and attendees 21+.
$PAOG closed up 8.33 percent on Monday, July 15, 2019, on 1.88 times normal volume.
$RBII business model specializing in physician and behavioral health facilities management for the treatment of substance abuse and mental health disorders.
Looking for a bounce after $RBII closed down 8.7 percent on Monday, July 15, 2019, on 1.17 times normal volume.
$PAOG very underrated ticker.
$RBII very undervalued still. Lots of room to run.
$RBII this treatment center will bring in $10 million in inpatient revenue and $5mil in outpatient revs.
$RBII this opioid crisis is a terrible thing, but its good to see the market rising to meet the challenge. There is some real hope in CBD based treatments.
Cannophen being launched definitely raises $RBII to a whole other tier. $RBII
$RBII acquiring SNB Health was a stroke of strategic genius.
$RBII Ohio tragically is the 2nd worst hit state for opioid overdose deaths nationwide. RBII is here to make a difference.
$RBII this thing is really going to run this week IMO.
Great place to debut Cannophen at the Cannabis Cup, there before all the luminaries of the sector. $PAOG
Release of Cannophen is a big move in this sector. $PAOG
$PAOG smells like we could have news here soon.
CBD only Cannophen coming soon, and that means we will be on track to really explode distribution. $PAOG
Cannophen™ capsules were available to attendees of the Cannabis Cup, which was open to Michigan medical marihuana cardholders 18+ and attendees 21+.
Each capsule features a 1:1 blend of premium THC distillate and full-spectrum CBD distillate, with laboratory test results showing 25mg THC and 25mg CBD per capsule (10 capsules per package, 250mg THC / 250mg CBD total). $PAOG
Cannophen™ is an oral capsule developed under the strict standards set forward by the pharmaceutical compounding industry.
$PAOG recently completed its first production run of Cannophen™ capsules in Michigan.
GM $PAOG
Agree PlanetETH, The Sanduskey treatment center can drive $5 million in outpatient treatment revenues as well. $RBII
$RBII is committed to fighting the opioid epidemic. Its the largest illicit drug epidemic to hit us in USA history.
Sanduskey Treatment facility will drive some major revenues. $RBII
Rare gem in this market. $RBII
Lots of growth potential still from here. $RBII